• Anoctamin 2 deletion alters dopamine-related signaling and impairs inhibitory behavioral control in mice
  Published on 2026-08-19
  4 weeks ago
• Altered thalamo–prefrontal synchrony dynamics during spatial working memory task performance in a SETD1A loss-of-function mouse model of schizophrenia predisposition
  Published on 2026-08-17
  4 weeks ago
• Epigenomic priming of microglia bridges psychopathology and late-life cognitive decline
  Published on 2026-08-15
  4 weeks ago
• Dopaminergic modulation of social reward anticipation in depression: neural effects of amisulpride versus placebo
  Published on 2026-08-14
  4 weeks ago
• The effect of theta-gamma coupling on response to cognitive remediation combined with transcranial direct current stimulation in older adults at high risk for dementia: a PACt-MD secondary analysis
  Published on 2026-08-13
  1 month ago
• From inflammaging to precision psychiatry: metabolic–immune crosstalk as a driver of late-life depression trajectories
  Published on 2026-08-13
  1 month ago
• Development of samarium-153 oxide loaded polystyrene radiotracer particles for gamma scintigraphy of whole gastrointestinal transit study
  Published on 2026-08-12
  1 month ago

« Previous 1 … 3 4 5 6 7 … 143 Next »

• The role of aripiprazole in modulating putamen and thalamus functional connectivity in early psychosis patients
  Published on 2026-07-28
  2 months ago
• Mediators of treatment response in a clinical trial of naltrexone and bupropion for methamphetamine use disorder: A longitudinal mediation analysis
  Published on 2026-07-27
  2 months ago
• Genetic background and sex moderate the effects of adolescent nicotine exposure on adult functional neural circuits and behavior
  Published on 2026-07-24
  2 months ago
• No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study
  Published on 2026-07-23
  2 months ago
• Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder
  Published on 2026-07-16
  2 months ago
• The increasing use of cognitive enhancing drugs by those with ADHD and neurotypical individuals: Societal demands, lifestyle preferences, and ethical issues
  Published on 2026-07-15
  2 months ago
• Acute behavioural effects of low-dose cannabidiol: A randomised crossover trial in healthy volunteers
  Published on 2026-07-15
  2 months ago

« Previous 1 … 3 4 5 6 7 … 154 Next »

• From association to screening: calibrating neurological risk in severe mental illness
  Published on 2026-05-29
  4 months ago
• Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers
  Published on 2026-05-29
  4 months ago
• Rethinking neurocognitive and cardiometabolic screening in severe mental illness
  Published on 2026-05-23
  4 months ago
• The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD✰
  Published on 2026-05-21
  4 months ago
• Response to Ma et al.
  Published on 2026-05-19
  4 months ago
• Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D study
  Published on 2026-05-19
  4 months ago
• Antidepressant use and colorectal cancer risk: A systematic review and meta-analysis of epidemiological studies
  Published on 2026-05-17
  4 months ago

« Previous 1 … 3 4 5 6 7 … 170 Next »